Transgene to Participate in the Biomed Forum Investor Conference

Strasbourg (France), January 21 , 2025, 5:45 PM CET – Transgene(Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, todayannounced that its management team will participate in the upcoming edition of the Biomed Forum, a conference for institutional investors. Organized by AllInvest Securities, this event will take place on February 4, 2025, in Paris. ***About Transgene Transgene (Euronext: TNG) is a...

Illkirch Graffenstaden, 21/01/2025 (informazione.news - comunicati stampa - economia)

***

Attachment